Enbee Trade and Finance Valuation
Is 512441 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 512441 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate 512441's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate 512441's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 512441?
Other financial metrics that can be useful for relative valuation.
| What is 512441's n/a Ratio? | |
|---|---|
| n/a | 0x |
| n/a | n/a |
| Market Cap | ₹192.80m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | n/a |
| Enterprise Value/EBITDA | n/a |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does 512441's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 14.9x | ||
GLFL Gujarat Lease Financing | 33.3x | n/a | ₹234.6m |
540360 Leading Leasing Finance And Investment | 8.2x | n/a | ₹253.9m |
539174 Helpage Finlease | 9.8x | n/a | ₹199.0m |
506365 Chemo Pharma Laboratories | 8.4x | n/a | ₹126.0m |
512441 Enbee Trade and Finance | 6.3x | n/a | ₹192.8m |
Price-To-Sales vs Peers: 512441 is good value based on its Price-To-Sales Ratio (6.3x) compared to the peer average (14.9x).
Price to Earnings Ratio vs Industry
How does 512441's PE Ratio compare vs other companies in the IN Diversified Financial Industry?
Price-To-Sales vs Industry: 512441 is good value based on its Price-To-Sales Ratio (6.3x) compared to the Indian Diversified Financial industry average (9x).
Price to Sales Ratio vs Fair Ratio
What is 512441's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 6.3x |
| Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate 512441's Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.